1. Home
  2. BN vs SNY Comparison

BN vs SNY Comparison

Compare BN & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BN
  • SNY
  • Stock Information
  • Founded
  • BN 1997
  • SNY 1994
  • Country
  • BN Canada
  • SNY France
  • Employees
  • BN N/A
  • SNY N/A
  • Industry
  • BN Other Consumer Services
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • BN Consumer Discretionary
  • SNY Health Care
  • Exchange
  • BN Nasdaq
  • SNY Nasdaq
  • Market Cap
  • BN 98.6B
  • SNY 116.5B
  • IPO Year
  • BN N/A
  • SNY N/A
  • Fundamental
  • Price
  • BN $65.80
  • SNY $48.52
  • Analyst Decision
  • BN Buy
  • SNY Buy
  • Analyst Count
  • BN 9
  • SNY 2
  • Target Price
  • BN $65.00
  • SNY $62.50
  • AVG Volume (30 Days)
  • BN 1.9M
  • SNY 2.1M
  • Earning Date
  • BN 08-07-2025
  • SNY 07-31-2025
  • Dividend Yield
  • BN 0.52%
  • SNY 3.29%
  • EPS Growth
  • BN N/A
  • SNY 39.56
  • EPS
  • BN 0.29
  • SNY 5.45
  • Revenue
  • BN $83,605,000,000.00
  • SNY $48,817,552,946.00
  • Revenue This Year
  • BN N/A
  • SNY $3.39
  • Revenue Next Year
  • BN $12.51
  • SNY $7.05
  • P/E Ratio
  • BN $229.53
  • SNY $8.91
  • Revenue Growth
  • BN N/A
  • SNY N/A
  • 52 Week Low
  • BN $42.21
  • SNY $45.80
  • 52 Week High
  • BN $65.78
  • SNY $60.12
  • Technical
  • Relative Strength Index (RSI)
  • BN 69.13
  • SNY 46.35
  • Support Level
  • BN $62.53
  • SNY $47.87
  • Resistance Level
  • BN $64.04
  • SNY $48.80
  • Average True Range (ATR)
  • BN 1.30
  • SNY 0.57
  • MACD
  • BN 0.14
  • SNY 0.11
  • Stochastic Oscillator
  • BN 100.00
  • SNY 49.16

About BN Brookfield Corporation Limited Voting Shares

Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals. It has seven operating segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity, Real Estate and Corporate Activities. It invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders. The company generates the majority of its revenue from Asset Management. It has a geographic presence in the UK, the United States, Australia, Canada, Brazil, India, Colombia, Germany, Other Europe, Other Asia, and other countries.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Share on Social Networks: